Granules India gains as its arm gets USFDA’s approval for Colchicine Capsules

30 Apr 2024 Evaluate

Granules India is currently trading at Rs. 426.25, up by 6.05 points or 1.44% from its previous closing of Rs. 420.20 on the BSE.

The scrip opened at Rs. 420.55 and has touched a high and low of Rs. 426.35 and Rs. 420.55 respectively. So far 7080 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 480.50 on 26-Feb-2024 and a 52 week low of Rs. 272.00 on 25-May-2023.

Last one week high and low of the scrip stood at Rs. 427.85 and Rs. 412.00 respectively. The current market cap of the company is Rs. 10314.00 crore.

The promoters holding in the company stood at 41.96%, while Institutions and Non-Institutions held 30.27% and 27.77% respectively.

Granules India’s wholly owned foreign subsidiary - Granules Pharmaceuticals, Inc (GPI) has received US Food & Drug Administration (USFDA) approval for its Abbreviated New Drug Application (ANDA) for Colchicine Capsules, 0.6 mg. It is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Mitigare Capsules, 0.6 mg of Hikma International Pharmaceuticals LLC (Hikma). Colchicine Capsules are indicated for prophylaxis of gout flares in adults. 

Granules now have a total of 64 ANDA approvals from the USFDA (63 Final approvals and 1 tentative approvals). The current annual U.S. market for Colchicine Capsules is around $55 Million, according to MAT February 2024, IQVIA/IMS Health.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).

Granules India Share Price

603.30 -14.00 (-2.27%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×